Startups
Combinostics
Combinostics is a Finnish medical software company developing AI-assisted imaging analysis and clinical decision support for neurological disorders. Its cNeuro platform quantifies brain MRI and nuclear-medicine images, combines imaging biomarkers with clinical and laboratory data, and helps clinicians assess conditions including dementia and multiple sclerosis. The software supports diagnosis, disease monitoring and research through cloud services and installations for healthcare providers. Founded in 2014, Combinostics was acquired by SyntheticMR in a transaction completed on January 2, 2025 and now operates as part of that medical-imaging group.
Founded 2014